Skip to Main Content

Paper Details

Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status.
Front Oncol
2
2022
Author NameAffiliation
Jaana OikkonenUniversity of Helsinki and Helsinki University Hospital
Krister WennerbergUniversity of Copenhagen
  • 1 - 2

Datasets

Release 1.2